The role of ubiquitin-proteasome pathway in oncogenic signaling

被引:0
作者
Fuchs, SY [1 ]
机构
[1] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA
关键词
ubiquitin; proteasome; signal transduction; oncogene; cancer;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Oncogenic activation of genes that regulate cell proliferation and survival plays a central role in the development of human cancer. This activation is frequently achieved by the aberrant expression of oncogene products due to the gene amplification, enhanced transcription or stabilization of their mRNA or protein. The ubiquitin-proteasome pathway (UPP) is the key player in the intracellular degradation of regulatory proteins in eukaryotes. UPP controls the abundance and activity of important protein regulators of cellular signal transduction including a variety of cellular proto-oncogenes. Alteration of ubiquitination and degradation of these proto-oncogene proteins often occurs during tumorigenesis and critically contributes to cell decisions as per proliferation/differentiation and survival/death. This article attempts to briefly overview the role of UPP in the regulation of several signal transduction pathways that contribute to development of cancer.
引用
收藏
页码:337 / 341
页数:5
相关论文
共 72 条
[1]   Degradation of cellular and viral Fos proteins [J].
Acquaviva, C ;
Ferrara, P ;
Bossis, G ;
Brockly, F ;
Salvat, C ;
Jariel-Encontre, I ;
Piechaczyk, M .
BIOCHIMIE, 2001, 83 (3-4) :357-362
[2]   Cellular and viral Fos proteins are degraded by different proteolytic systems [J].
Acquaviva, C ;
Salvat, C ;
Brockly, F ;
Bossis, G ;
Ferrara, P ;
Piechaczyk, M ;
Jariel-Encontre, I .
ONCOGENE, 2001, 20 (08) :942-950
[3]   Proteasome inhibition in cancer: Development of PS-341 [J].
Adams, J .
SEMINARS IN ONCOLOGY, 2001, 28 (06) :613-619
[4]   Degradation of the Epstein-Barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway - Targeting via ubiquitination of the N-terminal residue [J].
Aviel, S ;
Winberg, G ;
Massucci, M ;
Ciechanover, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) :23491-23499
[5]   c-Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover [J].
Bahram, F ;
von der Lehr, N ;
Cetinkaya, C ;
Larsson, LG .
BLOOD, 2000, 95 (06) :2104-2110
[6]   Regulatory functions of ubiquitination in the immune system [J].
Ben-Neriah, Y .
NATURE IMMUNOLOGY, 2002, 3 (01) :20-26
[7]   Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-κB [J].
Bhatia, N ;
Herter, JR ;
Slaga, TJ ;
Fuchs, SY ;
Spiegelman, VS .
ONCOGENE, 2002, 21 (10) :1501-1509
[8]   Alteration of proteolytic processing of c-Myb as a consequence of its truncation in murine myeloid leukemia [J].
Bies, J ;
Nazarov, V ;
Wolff, L .
LEUKEMIA, 1999, 13 (Suppl 1) :S116-S117
[9]   Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway [J].
Bies, J ;
Wolff, L .
ONCOGENE, 1997, 14 (02) :203-212
[10]   Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors [J].
Blagosklonny, MV .
ONCOGENE, 2001, 20 (03) :395-398